PFAS “Forever Chemicals” Reached Antarctica — And They Reached Your Water, Your Workplace, and Your Blood
You read the headline and something clicked. Scientists found per- and polyfluoroalkyl substances — PFAS, the “forever chemicals” — in penguin feathers in Antarctica, one of the most remote places on Earth. If these chemicals crossed oceans and settled into the feathers of birds that never left the ice, you already know what the real question is: if it reached there, what is it doing in you?
That question is the beginning of a toxic-tort case. Not the penguin finding itself — that is a scientific data point that confirms what regulators and plaintiffs’ lawyers have been arguing for years: PFAS does not break down, it does not stay where it was put, and it accumulates in living tissue. The caseable question is whether you were exposed to PFAS through a identifiable domestic pathway — contaminated drinking water, occupational contact with firefighting foam, industrial discharge into your community — and whether that exposure caused a diagnosable disease.
We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic-tort and catastrophic-injury cases, and this page is written for the person who just read about forever chemicals and is now sitting at a kitchen table wondering whether the kidney cancer diagnosis, the thyroid condition, or the testicular cancer that upended their family might be connected to something a chemical company put in the water years ago. That connection is real, it is scientifically supported, and it is the foundation of one of the largest mass-tort proceedings in the United States right now. But the path from reading a headline to building a case requires understanding what PFAS is, how it harms the body, who is responsible, and what the law lets you do about it. That is what this page delivers — the education, the governing law, the evidence clocks, and the honest evaluation of what a case like this is worth. If after reading you believe you may have a claim, the call is free, the consultation is confidential, and we do not get paid unless we win.
What Are PFAS “Forever Chemicals” — and Why They Earned That Name
PFAS is a family of thousands of synthetic chemicals developed starting in the 1940s, valued by manufacturers for an almost supernatural resistance to heat, water, and oil. That resistance is precisely the problem. The carbon-fluorine bond that gives PFAS its useful properties is one of the strongest chemical bonds in organic chemistry. It does not break down in nature — not in sunlight, not in water, not in soil, not in the human body. That is why they are called “forever chemicals.” Every PFAS molecule ever manufactured still exists somewhere in the environment.
The two most studied PFAS compounds are PFOA (perfluorooctanoic acid) and PFOS (perfluorooctanesulfonic acid). For decades, chemical manufacturers — primarily 3M and DuPont — produced these compounds in enormous quantities for use in consumer products (nonstick cookware, stain-resistant carpets, waterproof clothing, food packaging) and, critically, in aqueous film-forming foam (AFFF), the firefighting foam used at military bases, airports, fire-training facilities, and industrial sites across the country. The manufacturers knew decades ago that these chemicals were persistent, bioaccumulative, and harmful. Internal documents produced in litigation have shown that 3M and DuPont were aware of PFAS toxicity as early as the 1970s and continued production and distribution anyway.
The Antarctic penguin finding is not a surprise to the scientific community. It is a confirmation. PFAS travels through ocean currents, atmospheric transport, and the biological food chain. If it reaches penguins in Antarctica, it is in the fish you eat, the water you drink, and — if you lived near a contamination source — it is likely in your blood at levels the federal government now considers dangerous. The question is not whether PFAS is everywhere. The question is whether your exposure was high enough, and traceable enough, to have caused the disease you or your loved one is now fighting.
The Known Health Effects of PFAS Exposure
The science connecting PFAS to human disease is not speculative. It is grounded in one of the most extensive epidemiological investigations ever conducted: the C8 Science Panel, an independent panel of epidemiologists established as part of a class-action settlement between DuPont and residents of the Mid-Ohio Valley whose drinking water was contaminated with PFOA from a DuPont plant in Parkersburg, West Virginia. The panel studied approximately 69,000 people over seven years and issued its findings in 2012.
The C8 Science Panel found a “probable link” between PFOA exposure and six health conditions:
- Kidney cancer — the disease most strongly linked to PFAS exposure and the focus of the first personal-injury bellwether cases in the AFFF multidistrict litigation
- Testicular cancer — another cancer with a strong PFAS association
- High cholesterol — elevated serum cholesterol levels linked to PFOA exposure
- Thyroid disease — disruption of thyroid function documented in exposed populations
- Pregnancy-induced hypertension — including preeclampsia, linked to PFOA exposure during pregnancy
- Ulcerative colitis — an inflammatory bowel disease associated with PFOA exposure
Beyond the C8 findings, the world’s leading cancer authority has weighed in. The International Agency for Research on Cancer (IARC) — part of the World Health Organization — classified PFOA as Group 1, carcinogenic to humans, and PFOS as Group 2B, possibly carcinogenic to humans, following a working group meeting in Lyon, France, in November 2023. A Group 1 classification means the evidence is sufficient to conclude that PFOA causes cancer in humans. This is the same category that includes asbestos, benzene, and tobacco smoke.
The mechanism of harm is rooted in PFAS biology. These compounds bind to serum proteins and concentrate in the liver and kidney. They are not metabolized — the human body has no pathway to break them down. They persist in blood for years, with half-lives measured in years, not days. Proposed pathways of damage include endocrine disruption, oxidative stress, immune modulation, and interference with cellular signaling. PFAS also crosses the placenta and is present in breast milk, meaning exposure can pass from mother to child.
The C8 Science Panel concluded that a “probable link” exists between PFOA and kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis — findings that became the scientific foundation for thousands of personal-injury claims against the chemical manufacturers who produced and discharged these compounds.
If you have been diagnosed with one of these conditions and you lived, worked, or served at a location with known PFAS contamination — a military base where AFFF was used, a community near a chemical plant, a fire station where training foam was discharged — the science supports a causal connection. The legal question is whether that connection can be proven in your specific case, and that is where the evidence and the regulatory framework become the spine of everything.
How PFAS Contamination Becomes a US Toxic-Tort Claim
The Antarctic penguin finding is a scientific data point. It is not a lawsuit. A toxic-tort claim requires three things that the penguin study does not provide: a domestic exposure pathway, a diagnosed injury, and an identifiable responsible party.
The exposure pathways that create caseable claims:
Contaminated drinking water. This is the largest and most common pathway. PFAS discharged from chemical plants, military bases, airports, or fire-training facilities seeps into groundwater and municipal water supplies. If your public water system tested above the federal limit for PFOA or PFOS — or above any applicable state standard — and you drank that water for years before being diagnosed with kidney cancer, testicular cancer, or thyroid disease, the exposure pathway is documented and the connection is scientifically supported. Water utility testing records, residence history, and biomonitoring (serum PFAS blood testing) are the proof.
Occupational exposure — firefighters and military personnel. AFFF firefighting foam is the single largest concentrated source of PFAS exposure for workers. Firefighters — both military and civilian — who trained with AFFF, lived on bases where AFFF was used, or responded to fuel-fire emergencies where AFFF was discharged, absorbed PFAS through skin contact, inhalation, and contaminated groundwater on base. If you served as a firefighter or were stationed at a military base with documented AFFF use and later developed kidney cancer or testicular cancer, your occupational exposure is the pathway.
Industrial and community exposure. Communities near chemical manufacturing plants — like the Parkersburg, West Virginia, area where DuPont produced PFOA for decades — face elevated exposure through air emissions, groundwater contamination, and river discharge. If you lived near a known PFAS manufacturing or discharge site, your residential exposure history is the pathway.
Consumer product exposure. While most consumer-product exposure (nonstick pans, stain-resistant carpets, waterproof clothing) produces lower individual doses, it can contribute to total body burden. Consumer-product claims are harder to tie to a specific defendant and a specific injury, but they remain part of the broader PFAS litigation landscape.
The responsible parties are the chemical manufacturers who produced PFAS — 3M, DuPont and its corporate successors, and the AFFF foam manufacturers. We will name them and map their corporate structures below. The point here is simple: the penguin finding tells you PFAS is everywhere, but your case is built on your water, your workplace, your blood, and your diagnosis — connected to a company that made the chemical and put it into your environment.
The Federal Regulatory Framework That Proves Your Case
The regulatory landscape for PFAS has evolved rapidly, and every rule the government has written is a piece of evidence your case can use. Here is what the federal framework looks like as of mid-2026 — and what each rule means for a toxic-tort claim.
The EPA Drinking Water Standard: 4 Parts Per Trillion
In April 2024, the EPA finalized the first-ever federal drinking water standard for PFAS. The rule set the Maximum Contaminant Level (MCL) for PFOA and PFOS at 4.0 parts per trillion (ng/L) each — a number so vanishingly small it is roughly equivalent to a single drop of water spread across twenty Olympic swimming pools. The health-based Maximum Contaminant Level Goal (MCLG) was set at zero, meaning the EPA determined there is no level of PFOA or PFOS in drinking water that is free of health risk.
“EPA is finalizing… individual MCLs for PFOA and PFOS at 4.0 nanograms per liter (ng/L) or parts per trillion (ppt)… and is finalizing health-based Maximum Contaminant Level Goals (MCLGs) for PFOA and PFOS at zero.”
What this means for your case: if your water system tested above 4.0 ppt for PFOA or PFOS, it was above the federal health limit. That is not our lawyer’s opinion — that is the United States government saying the water was not safe to drink. The testing data that proves it is a public record, and it is the foundation of a contamination claim.
There is an important freshness caveat: as of May 2026, the EPA proposed to extend the compliance deadline for PFOA/PFOS from 2029 to 2031 and proposed to rescind the MCLs for four other PFAS compounds (PFHxS, PFNA, HFPO-DA/GenX, and the Hazard Index). The PFOA/PFOS 4.0 ppt limit remains the durable anchor. Any article or claim that references the other compounds’ specific limits should be re-verified against current EPA rulemaking before publication.
CERCLA: PFOA and PFOS Are Now Hazardous Substances
In May 2024, the EPA designated PFOA and PFOS as “hazardous substances” under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) — the Superfund law. This designation, effective July 8, 2024, means that any entity that releases one pound or more of PFOA or PFOS in a 24-hour period must report that release to the National Response Center and state/local emergency authorities.
What this means for your case: CERCLA liability is strict, joint-and-several, and retroactive. The company that owned the site, ran the facility, generated the waste, or transported the contamination can be held responsible for the entire cleanup — even for pollution that occurred decades ago. The company cannot defend by saying “we followed the rules at the time.” CERCLA does not ask whether the company was careful. It asks whether the company owned, operated, generated, or transported the contamination. If it did, the law lets the government — and, through related state-law claims, injured individuals — hold it accountable.
TSCA: Chemical Manufacturers Must Report What They Knew
Under the Toxic Substances Control Act (TSCA), the EPA finalized a rule in October 2023 requiring any person who manufactured or imported PFAS or PFAS-containing articles in any year since January 1, 2011, to report uses, production volumes, disposal, exposures, and known hazards. This rule forces chemical manufacturers to compile and disclose what they knew about PFAS dangers going back over a decade.
What this means for your case: the TSCA reporting filings are a road map to the manufacturers’ own knowledge. If a company reported high production volumes of PFOA near your water source and simultaneously reported known health hazards, that is the paper trail that connects their product to your exposure to your disease.
The Evidence These Rules Force Into Existence
Every one of these regulations forces a company to create and retain records — and those records are the skeleton of your case. Water utility testing data, CERCLA release reports, TSCA production and hazard disclosures, OSHA exposure monitoring records (which must be retained for 30 years for toxic substances), and the manufacturers’ own internal research and testing documents are all discoverable in litigation. The law made the company build the evidence. Our job is to get it before it disappears.
The AFFF Multidistrict Litigation — The Largest PFAS Proceeding in the Country
Thousands of PFAS personal-injury and water-contamination claims have been consolidated in a single federal court through the multidistrict litigation process. As of June 2026, the JPML reported:
MDL-2873, In re: Aqueous Film-Forming Foams Products Liability Litigation — 15,240 actions pending, before Judge Richard M. Gergel in the U.S. District Court for the District of South Carolina. This is the central proceeding for AFFF/PFAS claims — water-provider contamination suits, personal-injury claims, and property-damage cases all flow through this court.
The defendants in the AFFF MDL are the chemical manufacturers and foam producers who made and sold PFAS-containing firefighting foam:
- 3M Company — the primary manufacturer of PFAS compounds used in AFFF
- DuPont de Nemours / EIDP and Corteva — products of the DowDuPont corporate split, with liability allocated among them by agreement
- The Chemours Company — a 2015 spinoff from DuPont that holds much of the legacy PFAS liability (the spinoff is itself the corporate restructuring at the heart of the defendant shell game)
- Tyco Fire Products (Johnson Controls), Kidde-Fenwal, National Foam, and Chemguard — AFFF foam manufacturers and distributors
The Public-Water Settlements
The companies have already agreed to pay billions to resolve claims by public water providers — but these settlements are for water utilities, not for sick individuals:
- 3M agreed to pay between approximately $10.3 billion (present value) and up to $12.5 billion (nominal) over 13 years to U.S. public water systems for PFAS remediation. Final court approval was received in 2024. These settlements contain no admission of liability.
- DuPont, Chemours, and Corteva agreed to approximately $1.185 billion with public water providers, announced in June 2023. Again, no admission of liability.
What this means for you: the water-system money is for cities and utilities to clean up contamination. It is not a payout to an individual who drank the water and got cancer. The personal-injury cases — the claims of people who developed kidney cancer, testicular cancer, thyroid disease, or ulcerative colitis after PFAS exposure — are a separate and ongoing fight inside the same MDL.
The Personal-Injury Bellwether
The first AFFF personal-injury bellwether case was selected to focus on kidney cancer and had been set for trial in October 2025, but was postponed after the court identified a large backlog of unfiled cases. Bellwether cases are test cases — their outcomes help both sides evaluate the strength of the science and the likely range of verdicts across thousands of similar claims. No personal-injury bellwether verdict has been reached as of this writing, which means the personal-injury track is still being actively litigated and the science of specific causation is being fought out in court.
If you have a PFAS-related cancer diagnosis and an identifiable exposure pathway, your claim may belong in this MDL. The intake process requires documenting your exposure, your diagnosis, and the connection between them — which is exactly what a toxic-tort lawyer builds from the first conversation. You can learn more about our toxic-tort practice here.
Who May Be Liable — The Corporate Shell Game
The companies behind PFAS contamination are not single entities. They are corporate structures deliberately layered to separate the entity that made the chemical from the entity that holds the assets. Understanding this structure is essential because naming the wrong defendant — or missing the right one — can sink a case before the science ever reaches a jury.
3M Company is the original manufacturer of PFOS and a primary producer of PFAS compounds for decades. 3M disclosed internal documents in earlier litigation showing it knew about PFAS toxicity as early as the 1970s. The company has since announced it will exit PFAS manufacturing entirely by the end of 2025. Its settlement with public water providers — the $10.3 billion framework — is the largest PFAS settlement to date.
DuPont’s corporate restructuring is the shell game in its purest form. The DuPont that originally produced PFOA at its Parkersburg, West Virginia, plant no longer exists as a single entity. The DowDuPont merger and subsequent split created three companies: DuPont de Nemours (which holds certain liabilities), Corteva (the agriculture spinoff), and Chemours (the 2015 spinoff that was specifically created to hold DuPont’s performance chemicals division — and with it, much of the legacy PFAS liability). Liability among these three entities was allocated by agreement, but from a plaintiff’s perspective, all three may need to be named to ensure the right defendant is in the case.
The AFFF foam manufacturers — Tyco Fire Products (a Johnson Controls subsidiary), Kidde-Fenwal, National Foam, and Chemguard — are separate defendants from the chemical producers. They designed, marketed, and sold the firefighting foam that was the primary delivery mechanism for PFAS into military bases, airports, and fire-training facilities. They can be liable on product-liability and failure-to-warn theories independent of the chemical manufacturers’ liability.
What this means for your case: identifying the correct corporate entity — the one that made the chemical that contaminated your water or that made the foam you trained with — requires pulling corporate filings, EPA facility records, and water-system contamination data. A generalist who sues “DuPont” without naming Chemours and Corteva, or who sues a foam distributor without naming the chemical manufacturer, may leave the deepest pocket out of the case entirely. Our toxic-tort practice page describes how we approach these corporate structures.
The Evidence Clock — What Records Exist and How Fast They Disappear
Every toxic-tort case is a race against evidence destruction. The disease appears decades after the exposure, but the proof of what was in the air, the water, or the foam has a legal expiration date. Here is what exists, who holds it, and how fast it can die.
Water utility testing data. Under the EPA’s PFAS drinking water rule, public water systems must conduct initial monitoring by April 2027. Many systems have already tested voluntarily or under state requirements. The testing data — which shows exactly what was in your water and when — is a public record. But the raw sample data and the utility’s internal communications about contamination findings are retained on the utility’s own schedule. A preservation letter to the utility freezes those records before they cycle out.
OSHA exposure records — the 30-year vault. For occupational PFAS exposure at a facility that also had benzene or other regulated toxic exposures, OSHA requires employers to retain exposure-monitoring records for 30 years and medical-surveillance records for the duration of employment plus 30 years. These records — air sampling, personal monitoring badges, blood test results — are the proof of what a worker was breathing and absorbing. They were designed to outlast the latency period of occupational disease. But if the employer goes out of business, destroys records, or simply cannot locate them, the proof is gone. A records demand must go out early.
Military base AFFF use records. The Department of Defense has documented AFFF use at hundreds of military installations across the country. The military’s own records — AFFF procurement logs, fire-training schedules, spill reports, environmental site assessments — are the proof of occupational and residential exposure for service members and base residents. These records are subject to federal records-retention rules but can be difficult to obtain without a targeted request or litigation hold.
TSCA reporting filings. The manufacturers’ TSCA reports — production volumes, uses, disposal, and known hazards back to 2011 — are filed with the EPA. These are the manufacturers’ own admissions of what they made, where it went, and what they knew. The submission window for these reports has been repeatedly extended, so the database may be incomplete at any given moment. The absence of a public filing is not proof a company is clean — it may mean the filing deadline has not yet arrived.
The manufacturer’s internal research. The internal corporate documents — research studies, safety committee minutes, executive communications, marketing strategies, and risk assessments — are the heart of a failure-to-warn and punitive-damages case. These survive only if a litigation hold freezes them before the company’s routine document-destruction policies erase them. The preservation letter that goes to the manufacturer the day a case opens is the single most important early step in a PFAS case.
Biomonitoring — your blood. Serum PFAS testing (a blood test that measures the concentration of PFAS compounds in your bloodstream) is the proof that exposure reached your body. Unlike environmental data, which shows what was in the water or the air, biomonitoring shows what is in you. Elevated serum PFAS levels, combined with a documented exposure pathway and a connected diagnosis, are the three-legged stool of a PFAS personal-injury case. This evidence does not disappear — but it must be collected and preserved through proper medical channels, and the chain of custody must be unimpeachable.
The urgency is real. The records that prove your exposure are on clocks set by the companies that created the contamination. Federal law only requires some of these records to survive for a set number of years; after that, destruction is legal. The water testing data, the employer’s air-monitoring logs, the manufacturer’s internal documents — every one of them is perishable. The day you call a lawyer is the day the preservation letters go out, freezing the evidence before the companies’ own retention schedules let it disappear. If you want to understand why speed matters, our contact page is where that conversation starts.
The Medicine — How PFAS Harms the Body and How the Disease Is Proved
PFAS is a systemic toxicant. It does not target a single organ — it distributes throughout the body via serum proteins, concentrating in the liver, kidneys, and blood. The diseases it causes are the diseases of organs that were never built to process a chemical that refuses to break down.
Kidney cancer is the personal-injury disease most strongly linked to PFAS exposure and the focus of the AFFF MDL’s first bellwether. The C8 Science Panel found a probable link between PFOA and kidney cancer. IARC classified PFOA as Group 1, carcinogenic to humans. The mechanism is thought to involve oxidative stress, DNA damage in renal cells, and disruption of cellular signaling pathways that normally suppress tumor growth. Diagnostics include imaging (CT, MRI), biopsy, and pathological subtyping. The proof problem is that kidney cancer has other causes — smoking, obesity, hypertension — and the defense will argue your cancer came from one of those, not from PFAS. The counter is dose reconstruction: your documented exposure (water testing data or biomonitoring), the dose-response trends in the C8 data, and the proximity and duration of your exposure to the contamination source.
Testicular cancer is the second cancer with a strong C8 probable-link finding. It is a cancer of young men, which means the exposure-to-disease timeline is shorter than for solid tumors that take decades to develop. Firefighters and military personnel — the populations most heavily exposed to AFFF — are the primary plaintiffs in testicular cancer claims. Diagnostics include ultrasound, tumor markers (AFP, HCG, LDH), and orchiectomy with pathological confirmation.
Thyroid disease encompasses both functional disorders (hypothyroidism, hyperthyroidism) and structural disease (nodules, cancer). PFAS is an endocrine disruptor, and the thyroid is one of its target organs. Diagnostics include TSH, free T4, thyroid ultrasound, and biopsy where indicated.
Ulcerative colitis is an inflammatory bowel disease the C8 panel linked to PFOA exposure. The mechanism is thought to involve immune modulation — PFAS interferes with the immune system’s regulatory pathways, potentially triggering autoimmune responses in the colon. Diagnostics include colonoscopy with biopsy.
The latency problem. PFAS-related diseases can take years to decades to develop after exposure. This is why the discovery rule — discussed below — is so important. It is also why the defense will argue that you cannot connect a cancer diagnosed in 2024 to a chemical you were exposed to in the 1990s. The counter lives in the dose reconstruction, the biomonitoring, the C8 science, and the IARC classification. The science says the connection is real. The case is about proving it with your specific facts.
Lifetime cost. Kidney cancer treatment — surgery, immunotherapy, targeted therapy, and in advanced cases, long-term management — runs into the hundreds of thousands of dollars in medical costs alone, before lost earnings and the human toll on the family. Testicular cancer, while often treatable, carries its own surgical, chemotherapy, and surveillance costs plus the psychological impact on young men. Thyroid disease requires lifelong medication and monitoring. These are not one-time injuries. They are conditions that redefine a person’s future, and a damages model must account for the lifetime, not just the hospital stay.
The Statute of Limitations — When the Clock Starts and Why It May Not Be Too Late
The single most common reason people do not call a lawyer about a PFAS-related disease is the belief that too much time has passed. They were exposed in the 1990s. They were diagnosed in 2020. It is now 2026. Surely the deadline has passed.
It may not have.
In toxic-tort cases involving latent disease — cancer that appears years or decades after exposure — most states apply the discovery rule: the clock does not start ticking on the day you were exposed. It starts when you discovered, or by reasonable diligence should have discovered, both the injury and its connection to the exposure. If you were diagnosed with kidney cancer in 2022 but only learned in 2024 that your drinking water had been contaminated with PFAS above the federal limit, your clock may have started in 2024 — not decades ago.
“In actions involving latent injury or disease, the cause of action does not accrue until the plaintiff has discovered, or by reasonable diligence should have discovered, the injury and its cause.”
Every state has its own statute of limitations for personal-injury and wrongful-death claims — typically ranging from two to three years, but varying by jurisdiction. Some states impose an outer deadline called a statute of repose that can cut off a claim even before discovery, though many states have carved out exceptions for toxic exposure and latent disease. The specific deadline that applies to your case depends on your state, your exposure pathway, and when you learned — or should have learned — that PFAS may have caused your disease.
This is why the first conversation with a toxic-tort lawyer is not just about whether you have a case. It is about whether the clock is still running. If you are reading this page and wondering whether it is too late, the honest answer is: it depends on your state’s discovery rule, your date of diagnosis, and when you first connected your disease to PFAS exposure. Those are questions a lawyer answers in the first call — and that call is free.
What Your Case May Be Worth
A PFAS toxic-tort case is not a one-size-fits-all number. The value of your claim depends on the severity of your disease, the strength of your exposure evidence, the identity and resources of the defendant, and whether your case is part of the AFFF MDL or filed individually in state court. What follows is not a prediction — it is the framework for how a real number is built.
Economic damages are the losses you can put on a spreadsheet: past and future medical bills, lost wages, lost earning capacity, and the cost of ongoing treatment and monitoring. Kidney cancer treatment can run into the hundreds of thousands. A young firefighter diagnosed with testicular cancer may lose years of earning capacity during treatment and recovery. Thyroid disease requires lifelong medication and surveillance. A life-care planner builds the cost stream; a forensic economist reduces it to present value. These are real dollars, documented by real medical records, and they are not capped in most jurisdictions.
Non-economic damages are the human losses no receipt can measure: pain, suffering, emotional anguish, loss of enjoyment of life, the fear of recurrence, the toll on a family watching a loved one fight cancer. These are the damages a jury is asked to value based on the evidence of what the disease has done to the person’s life. In states that cap non-economic damages, these caps typically do not reach the economic stream — which is why rigorous economic proof matters most in capped jurisdictions.
Punitive damages are the damages meant to punish the defendant for conduct that was worse than negligence. In PFAS cases, the internal corporate documents showing that manufacturers knew about PFAS toxicity for decades and continued production — the documents that have already surfaced in the C8 litigation and the AFFF MDL — are the evidence that puts punitive damages on the table. Whether punitive damages are available, and whether they are capped, depends on your state’s law.
Wrongful death. If PFAS exposure contributed to the death of a loved one, the estate and the surviving family may bring a wrongful-death claim. If your family member died of kidney cancer and had a documented PFAS exposure pathway, the wrongful-death claim carries its own damages — the financial support the family lost, the companionship that was taken, and in some states, the value of the life itself. You can learn more about wrongful-death claims on our wrongful-death practice page.
Medical monitoring. For individuals with documented PFAS exposure but no current disease diagnosis, some states allow a claim for medical monitoring — the cost of regular screening to detect PFAS-related disease early, when treatment is most effective. This is a separate claim from a personal-injury suit and depends on state law.
The public-water settlements — 3M’s $10.3 billion and the DuPont/Chemours/Corteva $1.185 billion — are context for what these companies have already been forced to pay, not a prediction of what an individual injury claim is worth. Those were utility contamination claims. Individual personal-injury claims are valued on their own facts: the diagnosis, the exposure, the defendant’s conduct, and the lifetime cost of the disease. Past results depend on the facts of each case and do not guarantee future outcomes.
The Insurance and Corporate Defense Playbook — What to Expect
The companies that made PFAS and the insurers behind them have a playbook. It has been refined through decades of toxic-tort litigation — from asbestos to benzene to PCBs — and it is designed to do one thing: minimize what they pay. Here are the plays you should expect, and the counter to each.
Play 1: “Your cancer came from something else.” The defense will argue your kidney cancer was caused by smoking, obesity, hypertension, or random chance — not PFAS. They will hire an epidemiologist to testify that the general population gets kidney cancer at a certain rate and your diagnosis is consistent with background risk, not with chemical exposure. The counter is dose reconstruction: your documented exposure level (from water testing or serum biomonitoring), the C8 Science Panel’s probable-link finding, the IARC Group 1 classification of PFOA, and the dose-response trends in the peer-reviewed literature. The science says PFAS causes kidney cancer. Your job is to show it caused yours.
Play 2: “You cannot prove you were exposed to our chemical.” When multiple manufacturers produced PFAS over decades, each defendant points at the others. 3M says DuPont made it too. DuPont says Chemours holds the liability. Chemours says the foam manufacturers delivered it to the bases. The counter is the CERCLA strict-liability framework and the corporate-structure map: name every entity in the chain, from the chemical producer to the foam manufacturer to the facility that discharged it, and let the jury apportion responsibility. The law does not require you to prove which molecule came from which company — it requires you to prove the contamination caused your disease and that the defendants in the courtroom each contributed to it.
Play 3: “It is too late to sue.” The defense will argue the statute of limitations ran from the date of exposure, not the date of discovery. The counter is the discovery rule — the doctrine that in latent-disease cases, the clock starts when you knew or should have known of the injury and its cause. If you were diagnosed in 2022 and learned about the PFAS contamination in your water in 2024, your clock may have started in 2024. The specific rule depends on your state, and a toxic-tort lawyer evaluates it in the first conversation.
Play 4: “Our science is not settled.” The defense will argue that the C8 “probable link” finding is not the same as “causes,” and that IARC’s Group 1 classification is a hazard identification, not a specific-causation determination. Both of these statements are technically true — and both are answerable. The C8 panel’s standard (“probable link”) was a legal standard in a class-action settlement, not a scientific conclusion of specific causation. But the underlying epidemiology — the dose-response data, the biological mechanism, the peer-reviewed studies — supports specific causation when combined with your documented exposure and diagnosis. The defense’s argument is not that the science is wrong. It is that the science does not prove your case. That is a question for a jury, not a motion to dismiss.
Play 5: Delay. The defense will file motions, challenge expert witnesses under Daubert, seek continuances, and drag the case out — betting that the plaintiff will tire, settle cheap, or die. In the AFFF MDL, the court has pushed the personal-injury bellwether schedule back multiple times. The counter is persistence, resources, and a trial team that has the bandwidth to fight for years without blinking. That is what a firm with a toxic-tort practice brings.
The Proof Story — How a PFAS Case Is Actually Built
Here is how a PFAS toxic-tort case is built, step by step, from the first phone call to the number on a verdict form or settlement demand.
Week one: the intake and the exposure map. The first conversation is not about the disease. It is about the exposure. Where did you live? When? What was your water source? Did you serve at a military base? Which one? When? Did you train with firefighting foam? How often? For how many years? Did you work at a chemical plant, a refinery, or a fire-training facility? The exposure map is the skeleton — every address, every duty station, every job site is a potential contamination point that can be cross-referenced against EPA water-testing data, DoD AFFF use records, and facility environmental site assessments.
Week two: the medical records and the diagnosis link. The medical records establish the disease — the pathology report, the imaging, the treatment history, the treating physician’s opinion on causation. The link between the disease and the exposure is the heart of the case. For kidney cancer, it is the C8 probable-link finding, the IARC Group 1 classification, the dose-response literature, and your specific exposure level. For testicular cancer, it is the same science plus the occupational context of AFFF exposure. The medical records and the exposure map together build the causal chain.
Month one: the preservation letters. The moment a case is contemplated, litigation-hold letters go out — to the water utility (freeze testing data and internal communications), to the employer or military facility (freeze exposure records and environmental assessments), and to the manufacturer (freeze internal research, marketing materials, and corporate communications). These letters convert routine document-destruction into sanctionable spoliation. If the company destroys evidence after receiving the letter, the jury can be told to assume the worst about what was lost.
Month two through six: the records dump and the expert workup. Discovery produces the manufacturer’s internal documents — the research studies, the safety committee minutes, the executive emails, the risk assessments. These are the documents that show what the company knew and when. Simultaneously, the plaintiff’s experts — a toxicologist, an epidemiologist, a hydrogeologist, an occupational-medicine physician — build the specific-causation opinion that ties your exposure to your disease. The defense builds its own expert panel. The Daubert fight — over whether the experts’ methods are reliable enough to go to a jury — is often the most consequential battle in the case.
Month six through trial: depositions, bellwether positioning, and the number. The corporate executives are deposed under oath. The scientists are deposed. The treating physicians are deposed. The evidence is tested in the crucible of cross-examination. In the MDL, bellwether cases are selected and tried — and the outcomes of those trials shape settlement negotiations for the thousands of remaining cases. If your case is individual, it proceeds on its own track toward trial or settlement.
The number at the end — whether a verdict or a settlement — is built from all of it: the exposure map, the medical records, the manufacturer’s internal documents, the expert opinions, the lifetime cost of the disease, and the conduct of a company that knew it was poisoning people and kept going.
Your First Steps — What to Do If You Believe You Were Exposed to PFAS
If you have read this far and you are wondering whether PFAS exposure caused your disease — or your loved one’s disease — here is what to do, in order.
Step one: document your exposure pathway. Write down where you have lived, with dates and addresses, going back as far as you can. Note your water source at each address — municipal water, private well, base water system. If you served in the military, note every base, every duty assignment, and whether you trained with or were near AFFF firefighting foam. If you worked as a firefighter, note every station, every training exercise, and every incident where foam was used. If you worked at a chemical plant or industrial facility, note the employer, the dates, and the job duties. This is the exposure map. It is the foundation of your case.
Step two: gather your medical records. Obtain copies of your pathology reports, imaging studies, treatment records, and physician notes. If you have been diagnosed with kidney cancer, testicular cancer, thyroid disease, or ulcerative colitis, the diagnostic records are the proof of the injury. If a loved one has passed away from a PFAS-related cancer, obtain the death certificate and the medical records leading up to death.
Step three: check your water. If you lived on a public water system, contact the utility and request PFAS testing results for your service area. Many utilities have already tested under EPA requirements or state mandates. If you lived on a private well in an area near a military base, chemical plant, or fire-training facility, consider having your well tested by a certified laboratory. The EPA’s 4.0 ppt MCL for PFOA and PFOS is the benchmark — anything above that is above the federal health limit.
Step four: consider serum biomonitoring. A blood test can measure the concentration of PFAS in your serum. Elevated levels, combined with a documented exposure pathway and a connected diagnosis, are powerful evidence. Talk to your physician or a toxic-tort lawyer about whether biomonitoring is appropriate for your case.
Step five: do not sign anything from a defendant or insurer. If you receive a communication from a chemical company, a foam manufacturer, or their insurance representative — offering a quick payment, requesting a statement, or asking you to sign a release — do not respond. Do not sign. Do not give a recorded statement. These communications are designed to close your case cheaply before you understand what it is worth. Everything you say can and will be used to minimize your claim.
Step six: call a toxic-tort lawyer. The call is free. The consultation is confidential. The lawyer will evaluate your exposure pathway, your diagnosis, the statute of limitations in your state, and whether your case belongs in the AFFF MDL or should be filed individually. The lawyer will send the preservation letters that freeze the evidence. The lawyer will build the exposure map, retain the experts, and stand between you and a corporate defense machine that has been minimizing toxic-tort claims since asbestos.
You do not have to know whether you have a case before you call. You have to know whether you were exposed and whether you are sick. The lawyer figures out the rest.
Frequently Asked Questions
I just read about PFAS in penguin feathers. Does that mean I have a lawsuit?
No — the penguin finding is a scientific data point, not a legal claim. A lawsuit requires a domestic exposure pathway (contaminated drinking water, occupational AFFF exposure, or proximity to a contamination source), a diagnosed injury linked to PFAS (such as kidney cancer, testicular cancer, thyroid disease, or ulcerative colitis), and an identifiable responsible party (a chemical manufacturer or AFFF foam producer). If you have those three elements, you may have a case. The penguin study simply confirms what the science already shows: PFAS is everywhere, it does not break down, and it accumulates in living tissue.
I was a firefighter and used AFFF foam for years. Now I have kidney cancer. Do I have a claim?
You may. Firefighters are among the most heavily exposed occupational groups for PFAS, and kidney cancer is the disease most strongly linked to PFOA exposure in the C8 Science Panel findings and the IARC Group 1 classification. If you can document your AFFF training and use history, and your kidney cancer diagnosis is supported by pathology and imaging, the exposure-to-disease chain is the foundation of a toxic-tort claim. Your case may belong in the AFFF multidistrict litigation (MDL-2873) in the District of South Carolina. A toxic-tort lawyer can evaluate your exposure history and determine the right filing path.
My drinking water was contaminated with PFAS. How do I find out?
Contact your public water utility and ask for PFAS testing results for your service area. Under the EPA’s 2024 drinking water rule, public water systems must test for PFOA and PFOS and report results. Many states have their own testing and reporting requirements. If your water tested above 4.0 parts per trillion for PFOA or PFOS, it exceeded the federal Maximum Contaminant Level. If you lived on a private well near a military base, chemical plant, or fire-training facility, consider testing through a certified laboratory. Water testing data is the foundation of a contaminated-water exposure claim.
How long do I have to file a PFAS lawsuit?
The deadline depends on your state’s statute of limitations and whether the discovery rule applies. In most states, the clock for a toxic-tort claim starts when you discovered — or by reasonable diligence should have discovered — both your injury and its connection to PFAS exposure. If you were diagnosed with kidney cancer in 2022 but only learned in 2024 that your water was contaminated with PFAS, your deadline may have started in 2024. Some states have statutes of repose that impose an outer deadline regardless of discovery. The specific deadline for your case depends on your state, your exposure pathway, and your date of diagnosis. A toxic-tort lawyer evaluates this in the first call — and that call is free.
What diseases are linked to PFAS exposure?
The C8 Science Panel found a “probable link” between PFOA exposure and six conditions: kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis. IARC classified PFOA as Group 1 (carcinogenic to humans) and PFOS as Group 2B (possibly carcinogenic). The strongest personal-injury claims involve kidney cancer and testicular cancer, which are the focus of the AFFF MDL’s personal-injury bellwether cases.
The 3M settlement was over $10 billion. Does that mean I get a payout?
No. The 3M settlement (approximately $10.3 billion in present value) and the DuPont/Chemours/Corteva settlement (approximately $1.185 billion) are agreements with public water providers to fund PFAS remediation in public water systems. That money is for cities and utilities to clean up contamination — it is not a payout to individuals who were exposed and developed disease. Personal-injury claims — the claims of people who got sick — are a separate and ongoing fight in the AFFF MDL. If you have a PFAS-related disease and a documented exposure pathway, your claim is separate from the water-provider settlements.
I lived near a military base where AFFF was used. Is that enough for a case?
It can be. The Department of Defense has documented AFFF use at hundreds of installations, and PFAS from those installations has contaminated groundwater both on and off base. If you lived on or near a base with documented AFFF use, and you have been diagnosed with a PFAS-related disease, your residential exposure pathway may support a claim. The strength of the case depends on the documented contamination at your specific base, the duration of your residence, your water source, and your diagnosis.
How much does a PFAS lawyer cost?
Our firm handles toxic-tort cases on a contingency fee basis. That means we do not charge an hourly rate and we do not bill you for the cost of investigating your case. We are paid a percentage of the recovery — 33.33% before trial and 40% if the case goes to trial — and only if we win. If there is no recovery, you owe us nothing. The consultation is free. You can learn more about how contingency fees work on our FAQ video page.
What if my loved one died of kidney cancer and was exposed to PFAS?
If PFAS exposure contributed to your family member’s death, the estate and the surviving family may bring a wrongful-death claim. A wrongful-death case seeks compensation for the financial support the family lost, the companionship that was taken, the medical costs incurred before death, and in some states, the value of the life itself. The exposure pathway — documented AFFF use, contaminated water, or proximity to a contamination source — and the diagnosis of kidney cancer or testicular cancer are the foundation. The statute of limitations for wrongful-death claims varies by state and may be shorter than for personal-injury claims, so timing matters. Our wrongful-death practice page has more information.
Do I need to have my blood tested for PFAS to file a claim?
Serum PFAS biomonitoring — a blood test that measures PFAS concentration in your bloodstream — is powerful evidence that exposure reached your body, but it is not always required to file a claim. Environmental data (water testing results showing contamination above the federal MCL) combined with residence history and a connected diagnosis can be sufficient. Biomonitoring strengthens the case by showing your actual body burden. Whether it is appropriate for your case depends on your exposure pathway, your diagnosis, and the litigation strategy. A toxic-tort lawyer can advise you on this during the intake process.
How long does a PFAS case take?
Toxic-tort cases involving latent disease are not fast. The AFFF MDL was created in 2018 and is still ongoing as of 2026, with the first personal-injury bellwether cases not yet tried. Individual cases filed in state court may resolve faster or slower depending on the court’s docket, the complexity of the science, and the willingness of the defendant to settle. The manufacturer’s internal documents, the expert Daubert fights, and the deposition of corporate executives all take time. A realistic expectation is years, not months. But the preservation letters that freeze the evidence go out the day you call — so while the case takes time, the evidence is protected from the start.
Why Our Firm
Ralph P. Manginello has spent 27-plus years in courtrooms, including federal court. He is the Managing Partner of Attorney911 — The Manginello Law Firm, PLLC — and he is admitted to the U.S. District Court for the Southern District of Texas. Ralph was a journalist before he was a lawyer, which means he reads documents the way a reporter reads them — looking for the sentence the company did not want to write, the study it did not want to publish, the warning it chose not to give. In a PFAS case, those documents — the manufacturer’s internal research showing it knew about PFAS toxicity decades ago — are the spine of the failure-to-warn and punitive-damages case. Ralph’s attorney profile tells the full story.
Lupe Peña spent years inside a national insurance-defense firm before he joined our side of the table. He sat in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like the readers of this page. He knows how the defense values a toxic-tort claim, how it selects its expert witnesses, how it builds its Daubert challenge, and how it uses delay as a weapon. Now he uses that knowledge for injured clients. Lupe is fluent in Spanish and conducts full consultations in Spanish without an interpreter — because a family’s right to understand their legal options should never depend on whether the lawyer speaks their language. Lupe’s attorney profile is here.
Together, we handle toxic-tort, mass-tort, and catastrophic-injury cases with the resources and the persistence these fights require. We have recovered over $50 million for our clients — a figure that includes a $5 million-plus brain-injury settlement, a $3.8 million-plus amputation settlement, and a $2.5 million-plus truck-crash recovery. Past results depend on the facts of each case and do not guarantee future outcomes. What we guarantee is this: the consultation is free, the investigation costs you nothing, and we do not get paid unless we win your case.
Our fee is 33.33% before trial and 40% if the case goes to trial. We do not charge hourly. We do not bill for the cost of building your case. We absorb the risk because we believe the companies that poisoned the water should be the ones who pay — not the families who drank it.
The Bottom Line
PFAS is in Antarctic penguins. It is in the blood of nearly every person on Earth. And it is in the bodies of people who drank contaminated water, trained with firefighting foam, or lived near a chemical plant — people who are now fighting kidney cancer, testicular cancer, thyroid disease, and other conditions the science has linked to these chemicals.
The companies that made PFAS knew it was dangerous. They kept making it. They kept discharging it. They kept selling it. And when the science caught up with them, they restructured their corporations to wall off the liability — spinning off divisions, creating new entities, and hoping the families they exposed would never figure out who to sue.
We help families figure out who to sue. We build the exposure map. We send the letters that freeze the evidence. We work with the toxicologists and epidemiologists who can connect the chemical to the cancer. And we stand in front of the corporate defense machine that has been minimizing toxic-tort claims since asbestos and say: not this time.
If you were exposed to PFAS and you are sick — or someone you love was exposed and is gone — the call is free. The consultation is confidential. The evidence has a clock on it. Call 1-888-ATTY-911 — 24 hours a day, 7 days a week, live staff, not an answering service. Hablamos Español. We do not get paid unless we win your case.
This page is legal information, not legal advice. Every case is different. The specific statute of limitations, the available damages, and the identity of the correct defendants depend on your state, your exposure pathway, and your individual facts. Contacting the firm is free and confidential, and it is the only way to get an honest evaluation of whether you have a case worth pursuing.